SNO 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Memorial Sloan Kettering Cancer Center at SNO 2026

Nov 12–15, 2026 Philadelphia, PA ~3k attendees Website

Memorial Sloan Kettering Cancer Center brings 39 presentations to SNO 2026 in Philadelphia. Its program covers molecular pathology, clinical trials and health equity, including telehealth and decentralized trials that widen access to care. Work on CNS lymphoma, MET-altered gliomas and leptomeningeal disease also features.

OrganizationSNO 2026 Attendance
Hospitals & cancer centers
A cancer center providing patient care and conducting research across cancer types, including brain tumors and other neurological cancers.
Session
Thu Nov 12
8am–12:30pm
SNO Future Leaders Development Program - By Application Only
125, First Floor, Convention Center
Session
Thu Nov 12
4:30–5:35pm
Session
Fri Nov 13
8:30–10am
Plenary I
Exhibit Hall C, Second Floor, Convention Center
Talk
Fri Nov 13
10:49–10:54am
The genomic landscape of MET alterations in gliomas and responses to MET inhibition
120 ABC, First Floor, Convention Center · Abstract PATH-19
Pathology
Talk
Fri Nov 13
11:30–11:33am
Talk
Fri Nov 13
11:33–11:36am
Talk
Fri Nov 13
11:36–11:39am
Application of artificial intelligence to derive clinical risk factors associated with LMD progression
Exhibit Hall D & E, Second Floor, Convention Center · Abstract BIOM-53
Biomarkers
Talk
Fri Nov 13
12:09–12:12pm
Talk
Fri Nov 13
12:12–12:15pm
Multicenter study evaluating the clinical characteristics and treatment outcomes of low grade gliomas with oncogenic BRAF non-V600E SNV/indels
Exhibit Hall D & E, Second Floor, Convention Center · Abstract PTHP-03
Pathology · Pediatrics
Session
Fri Nov 13
12:45–2:15pm
Plenary II
Exhibit Hall C, Second Floor, Convention Center
Session
Fri Nov 13
2:30–3:30pm
Talk
Fri Nov 13
2:30–2:37pm
Session
Fri Nov 13
3:45–4:45pm
Session
Fri Nov 13
5–6pm
Cancer Neuroscience Oral Abstracts Session II
118 ABC, First Floor, Convention Center
Neuroscience
Talk
Fri Nov 13
5:39–5:44pm
Long-term outcomes of CNS lymphoma patients treated with glucarpidase
119 AB, First Floor, Convention Center · Abstract CTNI-33
Trials · Lymphoma
Poster
Fri Nov 13
7:30–9:30pm
Geographic Distribution of Neuro-Oncology Workforce in the USA
Exhibit Hall D & E, Second Floor, Convention Center · Abstract DISP-15
Health equity
Poster
Fri Nov 13
7:30–9:30pm
Financial Toxicity and Health-Related Social Risks Among Patients with Brain Metastases
Exhibit Hall D & E, Second Floor, Convention Center · Abstract DISP-16
Health equity
Poster
Fri Nov 13
7:30–9:30pm
Utility of Dynamic Contrast-Enhanced (DCE) MRI to predict Radiation Necrosis and Tumor Recurrence of Oligodendroglioma
Exhibit Hall D & E, Second Floor, Convention Center · Abstract IMG-57
Neuroimaging
Poster
Fri Nov 13
7:30–9:30pm
Primary CNS lymphoma mimicking brain metastases in a patient with metastatic renal cell carcinoma: A glucarpidase rescue case
Exhibit Hall D & E, Second Floor, Convention Center · Abstract INNV-21
Survivorship
Poster
Fri Nov 13
7:30–9:30pm
Treatment Strategies for Relapsed Medulloblastoma in the Pediatric Population
Exhibit Hall D & E, Second Floor, Convention Center · Abstract NCMP-22
Survivorship
Poster
Fri Nov 13
7:30–9:30pm
Poster
Fri Nov 13
7:30–9:30pm
Dose expansion of Debio 0123 (zedoresertib) plus temozolomide in patients with recurrent or progressive glioblastoma
Exhibit Hall D & E, Second Floor, Convention Center · Abstract TIP-05
Trials
Poster
Fri Nov 13
7:30–9:30pm
Modeling A Human FOSL2-Driven Macrophage State In Murine Glioma To Study Tumor Progression
Exhibit Hall D & E, Second Floor, Convention Center · Abstract TMIC-113
Tumor biology
Session
Sat Nov 14
8:30–10am
Plenary III
Exhibit Hall C, Second Floor, Convention Center
Session
Sat Nov 14
10:15–11:15am
Neurology of Cancer Oral Abstracts Session
119 AB, First Floor, Convention Center
Survivorship
Session
Sat Nov 14
11:30am–12:30pm
SNO Engagement Committee Meeting
122 AB, First Floor, Convention Center
Talk
Sat Nov 14
11:30–11:33am
Talk
Sat Nov 14
12–12:03pm
A pilot study of multimodal imaging using hyperpolarized [1-13C]pyruvate to distinguish tumor progression in glioma
Exhibit Hall D & E, Second Floor, Convention Center · Abstract IMG-87
Neuroimaging
Talk
Sat Nov 14
12:09–12:12pm
Genomic Landscape and Evolutionary Dynamics of RAS Alterations in Glioma: A Large-Scale Clinicopathologic Analysis
Exhibit Hall D & E, Second Floor, Convention Center · Abstract PATH-34
Pathology
Session
Sat Nov 14
12:45–2:15pm
Plenary IV
Exhibit Hall C, Second Floor, Convention Center
Session
Sun Nov 15
8:30–9:30am
Primary and Secondary CNS Lymphoma
Terrace Ballroom IV Convention Center
Lymphoma
Talk
Sun Nov 15
8:30–9:30am
Management of Relapsed CNS Lymphoma
Terrace Ballroom IV Convention Center
Lymphoma

Explore the full SNO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Philadelphia. Leave your work email and we’ll be in touch.

Privacy

Download the full SNO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Memorial Sloan Kettering Cancer Center

Tell us what you sell and we’ll find the people at Memorial Sloan Kettering Cancer Center most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the Society for Neuro-Oncology. Submit a correction